MedTrace Logo

Intraprostatic Injection of Botulinum Toxin A Versus Ethanol for Treatment of Patients With Benign Prostatic Hyperplasia

NCT03385161 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2017-12-28

No results posted yet for this study

Summary

To compare safely and efficacy of intraprostatic injection of botulinum toxin A versus ethanol for treatment of benign prostatic hyperplasia (BPH).

Conditions

  • Male
  • Ultrasonography
  • Botulinum Toxins, Type A
  • Injection; Complications, Infection
  • Prostatic Hyperplasia

Interventions

PROCEDURE

Botulinum toxin A

PROCEDURE

Ethanol

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Mohammed S ElSheemy, Ass. Prof. · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2015-06-30
Completion
2017-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03385161 on ClinicalTrials.gov